CD4+ CD25bright+ regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients

被引:53
作者
Velthuis, J. H. L. [1 ]
Mol, W. M. [1 ]
Weimar, W. [1 ]
Baan, C. C. [1 ]
机构
[1] Univ Med Ctr Rotterdam, Erasmus MC, Dept Internal Med, NL-3015 GD Rotterdam, Netherlands
关键词
immunosuppression; kidney transplantation; regulatory T cells; tolerance;
D O I
10.1111/j.1600-6143.2006.01566.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
CD4(+) CD25(bright+) FoxP3(+) T cells are potent regulators of T-cell reactivity, but their possible involvement in donor-specific nonresponsiveness after clinical kidney transplantation remains to be elucidated. We assessed the proliferative donor-reactivity in 33 kidney allograft recipients who were maintained on a combination of proliferation inhibitors (mycophenolate mofetil (MMF) or Azathioprine (Aza)) and prednisone, long (> 5 years) after transplantation. Of the 33 patients, 8 still exhibited donor-reactivity, whereas 25 were classified as donor nonreactive patients. Within these 25 donor nonreactive patients, we assessed the involvement of CD4(+) CD25(bright+) regulatory T cells both by depleting them from the responder population as well as by reconstituting them to the CD25(-/dim) effector population. The absence of proliferation in these 25 patients, was abolished in 7 (28%) recipients upon depletion of the CD4(+) CD25(bright+) T cells. Reconstitution of these cells suppressed the donor-reactivity in a dose-dependent manner. Adding-back CD4(+) CD25(bright+) T cells inhibited the anti-third party response in all recipients, indicating that functional CD4(+) CD25(bright+) T cells circulate despite more then 5 years of immunosuppressive treatment. Altogether, we conclude that in long-term immunosuppressed kidney allograft patients functional regulatory CD4(+) CD25(bright+) T cells circulate but that these cells mediate donor non reactivity only in a subset of patients.
引用
收藏
页码:2955 / 2964
页数:10
相关论文
共 39 条
  • [1] Induction of transplantation tolerance - the potential of regulatory T cells
    Akl, A
    Luo, SQ
    Wood, KJ
    [J]. TRANSPLANT IMMUNOLOGY, 2005, 14 (3-4) : 225 - 230
  • [2] Immunosuppressive drugs, the first 50 years and a glance forward
    Allison, AC
    [J]. IMMUNOPHARMACOLOGY, 2000, 47 (2-3): : 63 - 83
  • [3] Mycophenolate mofetil and its mechanisms of action
    Allison, AC
    Eugui, EM
    [J]. IMMUNOPHARMACOLOGY, 2000, 47 (2-3): : 85 - 118
  • [4] Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin in human on the induction of FOXP3 T cells
    Baan, CC
    van der Mast, BJ
    Klepper, M
    Mol, WM
    Peeters, AMA
    Korevaar, SS
    Balk, AHMM
    Weimar, W
    [J]. TRANSPLANTATION, 2005, 80 (01) : 110 - 117
  • [5] CD4+CD25high regulatory cells in human peripheral blood
    Baecher-Allan, C
    Brown, JA
    Freeman, GJ
    Hafler, DA
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (03) : 1245 - 1253
  • [6] Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: Implications for the pathogenesis of chronic allograft nephropathy
    Baker, RJ
    Hernandez-Fuentes, MP
    Brookes, PA
    Chaudhry, AN
    Cook, HT
    Lechler, RI
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (12) : 7199 - 7206
  • [7] Tr1 cells: From discovery to their clinical application
    Battaglia, M
    Gregori, S
    Bacchetta, R
    Roncarolo, MG
    [J]. SEMINARS IN IMMUNOLOGY, 2006, 18 (02) : 120 - 127
  • [8] Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells
    Coenen, JJA
    Koenen, HJPM
    van Rijssen, E
    Hilbrands, LB
    Joosten, I
    [J]. BLOOD, 2006, 107 (03) : 1018 - 1023
  • [9] Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling
    D'Cruz, LM
    Klein, L
    [J]. NATURE IMMUNOLOGY, 2005, 6 (11) : 1152 - 1159
  • [10] CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis
    de Kleer, IM
    Wedderburn, LR
    Taams, LS
    Patel, A
    Varsani, H
    Klein, M
    de Jager, W
    Pugayung, G
    Giannoni, F
    Rijkers, G
    Albani, S
    Kuis, W
    Prakken, B
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (10) : 6435 - 6443